Source: International Congress 2018 – Experimental research in pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Eichstaedt (Heidelberg, Germany), H. Mairbäurl (Heidelberg, Germany), J. Song (Heidelberg, Germany), N. Benjamin (Heidelberg, Germany), C. Fischer (Heidelberg, Germany), K. Hinderhofer (Heidelberg, Germany), E. Grünig (Heidelberg, Germany). Common genetic basis for pulmonary arterial hypertension and high altitude pulmonary edema. 3057

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary hypertension in children Source: Eur Respir Mon 2012; 57: 94-107 Year: 2012 The genetics of pulmonary arterial hypertension Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling Year: 2005 Towards a molecular classification of pulmonary arterial hypertension Source: Eur Respir J 2016; 48: 987-989 Year: 2016 Importance of environmental factors in pulmonary embolism and pulmonary arterial hypertension Source: International Congress 2019 – New trends in the management of pulmonary vascular disease Year: 2019 Single arterial occlusion to locate resistance in patients with pulmonary hypertension Source: Eur Respir J 2003; 21: 31-36 Year: 2003 Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology Source: Eur Respir Rev 2009; 19: 59-63 Year: 2010 Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 53 (6) 1802004; 10.1183/13993003.02004-2018 Year: 2019 Frequency of exercise induced pulmonary hypertension after pulmonary embolism Source: Eur Respir J 2006; 28: Suppl. 50, 401s Year: 2006 Pulmonary arterial hypertension in children Source: Eur Respir J 2003; 21: 155-176 Year: 2003 The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease Source: Eur Respir J 2013; 41: 217-223 Year: 2013 Systemic consequences of pulmonary arterial hypertension Source: International Congress 2019 – State of the art session: Pulmonary vascular diseases Year: 2019 COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey Source: ERJ Open Res, 6 (4) 00520-2020; 10.1183/23120541.00520-2020 Year: 2020 High-altitude disease Source: Respipedia Article Year: 2017 First histopathological evidence of irreversible pulmonary vascular disease in dasatinib-induced pulmonary arterial hypertension Source: Eur Respir J, 51 (3) 1701694; 10.1183/13993003.01694-2017 Year: 2018 Pulmonary function in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2004; 23: 637-648 Year: 2004 Lower than expected pulsatile pulmonary arterial load in a thromboembolic pulmonary hypertension model Source: International Congress 2018 – Experimental research in pulmonary hypertension Year: 2018 Comparison of exercise capacity and exercise haemodynamic relationships between severe group 3 pulmonary hypertension and pulmonary arterial hypertension Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016 Screening for pulmonary vascular disease (PVD) in patients with portal hypertension by investigating pulmonary hemodynamics during exercise Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension Year: 2017